Cover Image

The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound

Saved in:
Bibliographic Details
Main Authors: Kelm, Sörge (Author) , Gerlach, Judith (Author) , Brossmer, Reinhard (Author) , Danzer, Claus-Peter (Author) , Nitschke, Lars (Author)
Format: Article (Journal)
Language:English
Published: [May 6, 2002]
In: Journal of experimental medicine
Year: 2002, Volume: 195, Issue: 9, Pages: 1207-1213
ISSN:1540-9538
DOI:10.1084/jem.20011783
Online Access:Aggregator, kostenfrei, Volltext: http://dx.doi.org/10.1084/jem.20011783
Get full text
Author Notes:Soerge Kelm, Judith Gerlach, Reinhard Brossmer, Claus-Peter Danzer, and Lars Nitschke
Description
Item Description:Gesehen am 07.10.2016
Physical Description:Online Resource
ISSN:1540-9538
DOI:10.1084/jem.20011783

Similar Items